Blog
RSS FeedPosted by Michael Wonder on 09 Sep 2019
Will the UK run out of insulin and other vital medicines in a no-deal Brexit?
9 September 2019 - All but the most brazen companies aim to win their customers’ trust. But for businesses supplying ...
Posted by Michael Wonder on 04 Sep 2019
NHS funds eye gene therapy, after Novartis cuts £613,000 price
4 September 2019 - NICE has recommended the NHS should fund Novartis’ Luxturna for a rare eye disorder, after the ...
Posted by Michael Wonder on 04 Sep 2019
NICE recommends novel gene therapy treatment for rare inherited eye disorder
4 September 2019 - It's estimated that 86 people would be eligible for treatment with voretigene neparvovec in England. ...
Posted by Michael Wonder on 02 Sep 2019
NHS saves more than £700 million on medicines costs
2 September 2019 - The NHS has announced that it has saved more than £700 million from the annual medicines ...
Posted by Michael Wonder on 01 Sep 2019
NHS leaders warn of no-deal Brexit flu vaccine delays
30 August 2019 - A no-deal Brexit would make delays in the flu vaccine supply this year “likely”, according to ...
Posted by Michael Wonder on 29 Aug 2019
Assessing the health effects of a “no deal” Brexit
29 August 2019 - Boris Johnson says that the UK will leave the EU on the 31 October 2019, “do ...
Posted by Michael Wonder on 28 Aug 2019
Who could replace Sir Andrew Dillon at NICE?
28 August 2019 - With Sir Andrew Dillon announcing his retirement as chief executive of NICE, pharmaphorum discusses potential replacements ...
Posted by Michael Wonder on 28 Aug 2019
Batten disease treatment: parents can take fight to High Court
28 August 2019 - Two sets of parents of children with a rare degenerative disease can take a fight for ...
Posted by Michael Wonder on 27 Aug 2019
Incorporating affordability concerns within cost-effectiveness analysis for health technology assessment
27 August 2019 - New framework considers the scale, time profile, and uncertainty of budget impacts. ...
Posted by Michael Wonder on 25 Aug 2019
Cannabis oil too expensive to prescribe to epileptic children on NHS, advisory body finds
23 August 2019 - A cannabis drug used to treat children with epilepsy is too expensive to prescribe even though ...
Posted by Michael Wonder on 23 Aug 2019
NICE to work with company on addressing issues in appraisals of cannabidiol for treating difficult to control epilepsies
23 August 2019 - NICE has today announced its intention to work with GW Pharma to address the issues highlighted by ...
Posted by Michael Wonder on 22 Aug 2019
Sir Andrew Dillon to stand down as NICE chief executive
22 August 2019 - Sir Andrew Dillon has announced his intention to stand down as NICE chief executive next year. ...
Posted by Michael Wonder on 22 Aug 2019
ABPI position on US trade deal and medicines pricing
21 August 2019 - In response to concerns about the impact a US trade deal would have on medicine pricing, ...
Posted by Michael Wonder on 21 Aug 2019
NICE’s fast-track catapults Skyrizi into market
21 August 2019 - Watchdog also gives direction on comparing rival treatments. ...
Posted by Michael Wonder on 21 Aug 2019
NHS to reimburse Hemlibra
21 August 2019 - NHS England has commissioned Roche and Chugai’s joint haemophilia A drug, Hemlibra (emicizumab), agreeing to fund ...